Depression Treatment Failure Burdens Patients' Life and Wallets Even mild cases tied to reduced quality of life and high medical costs, survey showed Sep 21, 2022
Comorbidities May Stall Diagnosis of PTSD in the General Population Analysis shows that many patients are treated for symptoms of the disorder before diagnosis Sep 21, 2022
Low-Dose Cariprazine for MDD Tied to Anxiety Reduction Potential add-on therapy also improved most individual depressive symptoms on MADRS Sep 20, 2022
No Weird Dreams for Insomnia Patients Taking Lemborexant Even at 10 mg, the sleep aid resulted in few abnormal dreams or nightmares Sep 20, 2022
Trazodone Commonly Used Off-Label for Insomnia Not much data to support efficacy or safety "as a surrogate hypnotic medication," researcher says Sep 20, 2022
Rexulti Calms Alzheimer's Dementia-Related Agitation But atypical antipsychotic disappoints in borderline personality disorder Sep 19, 2022
Novel Combo for Schizophrenia Succeeds in Phase III Trial Xanomeline-trospium has potential to be first-in-class therapy for schizophrenia if approved Sep 19, 2022
Improvements in Treatment-Resistant Depression With Esketamine Pooled data from randomized trials showed better scores on the PHQ-9 as well Nov 02, 2021
Lemborexant Helps Insomniacs Catch More Z's Even patients with history of depression had better sleep outcomes Nov 02, 2021
Novel Oral Antidepressant Shows Rapid Symptom Improvement Improvement with 50-mg zuranolone seen by day 3 Nov 02, 2021
Is Earlier Use of Long-Acting Injectable Drugs for Schizophrenia Better? Early use linked to fewer inpatient stays and ER visits, study finds Nov 01, 2021
Extended-Release Risperidone Injectable Staves Off Schizophrenia Relapse Phase III RISE study found benefit with both once-monthly and bimonthly dose Nov 01, 2021
COVID Doesn't Dampen LAI Antipsychotic Prescribing in Schizophrenia Survey study shows no major changes in prescription trends in 2020 Nov 01, 2021
Migraine Drug Shows Benefit for Those With Comorbid Depression, Anxiety Real-world study of fremanezumab found that patients were able to reduce antidepressant use Nov 01, 2021
Antipsychotic Patch Quiets Schizophrenia-Related Hostility Most significant improvement seen with highest asenapine transdermal dose Oct 31, 2021
Trial: Drug Induces, Maintains Dementia-Related Psychosis Remission Results pave way for Nuplazid label expansion Sep 14, 2020
Long-Term Gains with Austedo in Tardive Dyskinesia Most robust improvement seen in people with more severe disease Sep 13, 2020
Lemborexant Boosts Sleep Outcomes in Insomnia SUNRISE 2 trial shows better sleep onset, maintenance, and quality Sep 12, 2020
Schizophrenia Tx Eases Depression in Bipolar Disorder Lumateperone offers greater rate of response, remission versus placebo Sep 12, 2020
Abuse-Deterrent Amphetamine Shines for Adult ADHD AR19 formulated with physical and chemical barriers against misuse Sep 12, 2020
Add-On Nuplazid Gets a Win in Early Schizophrenia Trial Phase II study met primary efficacy endpoint Sep 11, 2020
Oral Postpartum Depression Drug Reduces Symptoms for New Moms Interestingly, drug flopped in a trial last year for major depressive disorder Sep 11, 2020
Overweight Patients Less Likely to Gain Weight on Antipsychotic Analysis looked at users of brexpiprazole (Rexulti) Oct 07, 2019
Esketamine Nasal Spray Reduces Depression in Suicidal Patients Positive results from first global registration program of patients with active suicidal ideation, intent Oct 06, 2019
Novel Combo Tx Shows Durable Antipsychotic Effects Almost half of patients with schizophrenia deemed PANSS responders with samidorphan/olanzapine Oct 06, 2019
PM Stimulant Eases Daily Life for Kids With ADHD Parent-reported outcomes positive with delayed- and extended-release methylphenidate Oct 05, 2019
Injectable vs Oral Antipsychotics: Patients Have Preferences Long-acting injectables generally endorsed, but some still favor daily pills Oct 05, 2019
